lifestyle.californiaconsumerbanking.com

Author: GENFIT S.A.

GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents

May 11, 2026
GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025)

May 6, 2026
GENFIT Announces Publication of the 2025 Universal Registration Document

May 5, 2026
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update

May 5, 2026
GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF

May 4, 2026
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales

March 10, 2026